Compugen | CGEN - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Arca Biopharma USD 1.2B 82.6M 2026-09
aTyr Pharma USD 33.98M 14.81M 2026-09
Bio Path USD -8.49M 482K 2026-03
Brainstorm Cell Therapeutics USD -11.6M 588K 2026-06
Cara Therapeutics USD 14.5M 6.44M 2026-03
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 88.73M 6.62M 2026-06
Immunic USD 151.23M 157.91M 2026-03
Minerva Neurosciences USD -140.75M 106.17M 2025-12
RedHill Biopharma USD -1.08M 5.35M 2026-06
TherapeuticsMD USD 27.67M 990K 2024-06